|1.||De Vliegher, S: 17 articles (08/2015 - 12/2008)|
|2.||Piepers, S: 11 articles (08/2015 - 07/2009)|
|3.||Barkema, H W: 9 articles (03/2015 - 12/2001)|
|4.||Patel, Robin: 9 articles (03/2015 - 10/2004)|
|5.||Taponen, Suvi: 9 articles (01/2013 - 06/2006)|
|6.||Krediet, Tannette G: 9 articles (11/2012 - 03/2004)|
|7.||Lambert, P A: 9 articles (05/2007 - 05/2000)|
|8.||Schwarz, Stefan: 8 articles (06/2015 - 05/2006)|
|9.||Fowler, Vance G: 8 articles (04/2015 - 11/2004)|
|10.||Söderquist, B: 8 articles (07/2012 - 01/2006)|
09/01/2003 - "These results suggest that the VITEK 2 system can provide rapid, accurate, and reliable species-level identification of staphylococci responsible for bloodstream infections, although there is room for improvement in the identification of certain coagulase-negative species, especially S. "
11/01/2001 - "The frequent involvement of group B streptococci and coagulase-negative staphylococci requires empiric antibiotic therapy, effective for these pathogens, in all infants with suspected infection, waiting for blood cultures and antibiotic susceptibility results. "
01/01/2014 - "The aim of this study was to evaluate vaccine efficacy of a commercial vaccine (Startvac, Hipra Spain) aimed at reducing intramammary infections (IMI) with Staphylococcus aureus and coagulase-negative staphylococci under field conditions. "
01/01/2014 - "Efficacy of vaccination on Staphylococcus aureus and coagulase-negative staphylococci intramammary infection dynamics in 2 dairy herds."
01/01/2013 - "Further work is required to determine if this translates into increased efficacy in preventing infection, particularly against coagulase-negative staphylococci."
06/01/1995 - "Thus standard antibiotic treatment may be effective in the absence of tunnel sepsis in the majority of CRS cases due to non-virulent bacteria (mainly Staph coagulase negative species). "
01/01/2016 - "A study was conducted to evaluate the impact of implementing the Staphylococcus QuickFISH assay (AdvanDx, Woburn, MA), which rapidly detects and differentiates Staphylococcus aureus from coagulase-negative staphylococci (CoNS), together with an antimicrobial stewardship program on treating patients suspected of having sepsis. "
02/01/2014 - "The objective of this study was to examine the impact of Coagulase-negative staphylococcus (CoNS) sepsis in preterm infants on the neurodevelopmental outcomes at 30 to 42 months corrected age (CA). "
01/01/2011 - "The trial includes patients with culture confirmed (at least one positive culture from normally sterile site except coagulase negative staphylococci in addition to one clinical or laboratory criterion) or clinical sepsis (at least two laboratory and two clinical criteria suggestive of LOS in subjects with postmenstrual age < 44 weeks or fulfilment of criteria established by the International Pediatric Sepsis Consensus Conference in subjects with postmenstrual age ≥ 44 weeks). "
07/01/2007 - "This study aimed to determine clinical characteristics of coagulase-negative staphylococcal (CoNS) sepsis in neonates, to assess the molecular epidemiology and biofilm forming properties of isolated strains, and to assess antibiotic susceptibility of clonal compared with incidentally occurring strains. "
10/01/2004 - "We validate previous studies showing a decrease in the proportion of peritonitis episodes that are caused by coagulase-negative staphylococci. "
10/01/2004 - "Coagulase-negative Staphylococcus was the most common cause of peritonitis (29%), although this rate is lower than in historic studies. "
07/01/2013 - "The rate of peritonitis was 0.63 ep./yr, rates by microorganism were 0.18 ep./yr for coagulase-negative Staphylococcus, 0.12 ep./yr for Staphylococcus aureus and Gram negative. "
03/01/2013 - "In unadjusted analyses, patients in the highest BMI quartile (median: 33.5; interquartile range: 31.9 - 36.4) had an increased risk of peritonitis overall, and also an increased risk of peritonitis with gram-positive organisms and coagulase-negative Staphylococcus (CNS). "
05/01/2012 - "Coagulase-negative Staphylococcus was the organism most likely to cause peritonitis more than once in a given patient, and a prior CNS peritonitis was associated with an increased risk of CNS peritonitis within the subsequent year."
08/01/2005 - "A meta-analysis of studies performed in developed countries showed a trend of increasing risk for coagulase-negative staphylococcal infection. "
06/01/2004 - "A screened human polyclonal antibody and a humanized chimeric monoclonal antibody are both under investigation (in phase II-III clinical trials) for prevention of coagulase-negative staphylococcal infections in high-risk neonates. "
03/01/2003 - "A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units."
11/01/1994 - "Our data corroborate previous studies indicating risk factors and predictors of coagulase-negative staphylococcal infection."
03/01/2015 - "Challenges of diagnosing coagulase-negative staphylococcal infections result in conflicting definitions and inconsistent clinical practice. "
06/01/1990 - "Five bacteremias (two with Streptococcus pneumoniae and one each with Staphylococcus aureus, Proteus mirabilis, and a coagulase-negative staphylococcus) were eradicated. "
11/01/1977 - "None of the six coagulase-negative patients with staphylococcal bacteremia nor any of the 92 controls had titers exceeding 1:1. A total of 10% of the other patients with bacteremia showed positive results on the TAA test at low titer levels. "
06/01/2014 - "The aim of this study is to determine the species distribution, slime activity, and methicillin resistance of coagulase-negative staphylococci (CoNS) isolated from blood cultures as either contaminants or true bacteremia agents. "
08/01/2011 - "This study sought to expand current knowledge on the clinical and epidemiological characteristics of persistent coagulase-negative Staphylococcus (CoNS) bacteremia in very-low-birth-weight (VLBW) infants. "
01/01/2010 - "The micro-organisms encountered in the study are as follows:- 1) Staphylococcus albus coagulase negative, 2) Klebsiella, 3) Psedomonas aerugenosa, 4) Streptococcus viridans, 5) Alpha hemolytic streptococcus, 6) Neisseria catarrhalis On the basis of the study, it is concluded that the incidence of postoperative bacteremia following periodontal flap surgery is not as high as previously reported. "
|2.||Anti-Bacterial Agents (Antibiotics)
|2.||Continuous Ambulatory Peritoneal Dialysis (CAPD)
|3.||Neonatal Intensive Care
|5.||Prostheses and Implants (Prosthesis)